tiprankstipranks
Gilead Sciences (GILD)
NASDAQ:GILD
US Market

Gilead Sciences (GILD) Income Statement

Compare
13,157 Followers

Gilead Sciences Income Statement

Last quarter (Q4 2024), Gilead Sciences's total revenue was $7.57B, an increase of 6.38% from the same quarter last year. In Q4, Gilead Sciences's net income was $1.78B. See Gilead Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 28.75B$ 27.12B$ 27.28B$ 27.30B$ 24.69B
Gross Profit
$ 22.50B$ 20.62B$ 21.62B$ 20.70B$ 20.12B
Operating Expenses
$ 20.84B$ 13.67B$ 10.65B$ 10.61B$ 10.19B
Depreciation and Amortization
$ 0.00$ 2.69B$ 2.10B$ 2.05B$ 1.48B
EBITDA
$ 1.66B$ 10.50B$ 8.85B$ 11.33B$ 4.13B
Operating Income
$ 1.66B$ 7.61B$ 7.33B$ 7.41B$ 7.03B
Other Income/Expenses
$ -972.00M$ -746.00M$ -1.52B$ 872.00M$ -2.40B
Pretax Income
$ 690.00M$ 6.86B$ 5.81B$ 8.28B$ 1.67B
Net Income
$ 480.00M$ 5.67B$ 4.59B$ 6.22B$ 89.00M
Per Share Metrics
Basic EPS
$ 0.38$ 4.54$ 3.66$ 4.96$ 0.07
Diluted EPS
$ 0.38$ 4.50$ 3.64$ 4.93$ 0.07
Weighted Average Shares Outstanding
1.25B 1.25B 1.25B 1.26B 1.26B
Weighted Average Shares Outstanding (Diluted)
1.25B 1.26B 1.26B 1.26B 1.26B
Currency in USD

Gilead Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis